All stock reports

EMCURE evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-07T14:00:38.500049+00:00

Metrics

latest_annual_period
2026-03-31
revenue
92035400000.0
net_income
9243610000.0
operating_cash_flow
8505280000.0
free_cash_flow
4899680000.0
total_assets
96124810000.0
total_liabilities
46358080000.0
total_equity
49500320000.0
cash
1366580000.0
total_debt
15212410000.0
revenue_growth
0.17869115966902283
earnings_growth
0.3566968819899843
net_margin
0.10043537595316585
roe
0.18673838876193125
debt_to_equity
0.3073194274299641
cash_conversion
0.9201253622772921
free_cash_flow_margin
0.053236906668521024
trailing_pe
41.2175
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
7.581
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-f1fdb723054a9edacf3b78c19d6aa910cbd0bad921ea5e05042d3eb7fac10f70
Policy
stock-decisions-v1
Evidence bundle hash
bc6c2142bdc02a0195c27b11a8b634882c08682a0a6027e52ef49715063f32ff
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 4fc3851cdb9d3a34562aef149e9ff77889146beb73700de16637e5b8323d3cea
  • daily-price: 1c33a2df5ee4b3a0a90293a961204d45d438d19f19c159e9543044fd95144314
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric revenue growth is 0.17869115966902283. The cached financial metric roe is 0.18673838876193125. The cached financial metric net margin is 0.10043537595316585. The trailing 250-session price return was 51.72%. Average cached traded value over twenty sessions was INR 417,454,756.

Risks

The closing price was -3.22% below its highest close in the available trailing year. The trailing 5-session price return was -0.38%. The cached financial metric free cash flow margin is 0.053236906668521024. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-07T14:00:38.500049+00:00 from EODHD. The cached financial metric latest annual period is 2026-03-31.

Cached observations and evidence limits